Specifically, without growth-factor-activated Ras, these compounds could bind CRABP1 to activate ERK1/2 to target protein phosphatase 2 (PP2A), ultimately inducing apoptosis in cancer cells. This evidence concerns the gene CRABP1 and cancer.